BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16127523)

  • 1. The expression of bcl-2 in chronic liver diseases.
    Mutluay R; Ozenirler S; Poyraz A
    Saudi Med J; 2005 Aug; 26(8):1245-9. PubMed ID: 16127523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of Ki-67, transforming growth factor beta1, and B-cell lymphoma-leukemia-2 in liver tissue of patients with chronic liver diseases.
    Piekarska A; Piekarski J; Omulecka A; Szymczak W; Kubiak R
    J Gastroenterol Hepatol; 2006 Apr; 21(4):700-10. PubMed ID: 16677156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Bax, Bcl-xL and Bcl-2 proteins in relation to grade of inflammation and stage of fibrosis in chronic hepatitis C.
    Piekarska A; Kubiak R; Omulecka A; Szymczak W; Piekarski J
    Histopathology; 2007 Jun; 50(7):928-35. PubMed ID: 17543083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of c-kit protooncogen in hepatitis B virus-induced chronic hepatitis, cirrhosis and hepatocellular carcinoma: has it a diagnostic role?
    Kara B; Doran F; Kara IO; Akkiz H; Sandikci M
    Int J Clin Pract; 2008 Aug; 62(8):1206-11. PubMed ID: 18284441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bcl-2 protein expression in acute and chronic hepatitis, cirrhosis and hepatocellular carcinoma.
    Nakopoulou L; Stefanaki K; Vourlakou C; Manolaki N; Gakiopoulou H; Michalopoulos G
    Pathol Res Pract; 1999; 195(1):19-24. PubMed ID: 10048090
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of cytokines, oxidative stress and expression of BCL-2 in the pathogenesis of non-alcoholic steatohepatitis.
    Torer N; Ozenirler S; Yucel A; Bukan N; Erdem O
    Scand J Gastroenterol; 2007 Sep; 42(9):1095-101. PubMed ID: 17710676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic analysis in chronic hepatitis B patients: a retrospective study of 216 cases about Scheuer scores, in situ expression of viral antigens and tissue hepatitis B virus DNA levels.
    Zhu R; Huang H; Zhang H; Wang Z; Hu X; Zhai W; Lin Y; Wang J; Zhu H
    Liver Int; 2006 Feb; 26(1):82-9. PubMed ID: 16420513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical expression of CD95 (Fas), c-myc and epidermal growth factor receptor in hepatitis C virus infection, cirrhotic liver disease and hepatocellular carcinoma.
    El-Bassiouni A; Nosseir M; Zoheiry M; El-Ahwany E; Ghali A; El-Bassiouni N
    APMIS; 2006 Jun; 114(6):420-7. PubMed ID: 16856963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early mortality in Taiwanese lamivudine-treated patients with chronic hepatitis B-related decompensation: evaluation of the model for end-stage liver disease and index scoring systems as prognostic predictors.
    Dai CY; Chuang WL; Hou NJ; Lee LP; Hsieh MY; Lin ZY; Chen SC; Huang JF; Hsieh MY; Wang LY; Tsai JF; Wen-Yu ; Yu ML
    Clin Ther; 2006 Dec; 28(12):2081-92. PubMed ID: 17296464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An immunohistochemistry study of tissue bcl-2 expression and its serum levels in breast cancer patients.
    Alireza A; Raheleh S; Abbass R; Mojgan M; Mohamadreza M; Gholamreza M; Shadi B
    Ann N Y Acad Sci; 2008 Sep; 1138():114-20. PubMed ID: 18837891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased caspase-3 and altered expression of apoptosis-associated proteins, Bcl-2 and Bax in lichen planus.
    Abdel-Latif AM; Abuel-Ela HA; El-Shourbagy SH
    Clin Exp Dermatol; 2009 Apr; 34(3):390-5. PubMed ID: 19309373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatic clearance of 99mTc-p-butyl HIDA in liver diseases. Correlations with routine hematochemical parameters of liver function].
    Custro N; De Francisci MC; Patanella I; Scafidi V; Indovina I
    Minerva Med; 1984 Nov; 75(42):2527-32. PubMed ID: 6083507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced expression of Bcl-2 in lymphocytes infiltrating into the liver of patients with primary biliary cirrhosis.
    Deguchi A; Arima K; Masaki T; Yachida M; Nakai S; Ito T; Kita Y; Kurokohchi K; Watanabe S; Kuriyama S
    Int J Mol Med; 2002 Jun; 9(6):571-7. PubMed ID: 12011972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of apoptotic markers BCL-2 and Bax in chronic hepatitis C virus patients.
    Hanafy SM; Shehata OH; Farahat NM
    Clin Biochem; 2010 Sep; 43(13-14):1112-7. PubMed ID: 20627094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
    Chuma M; Hige S; Nakanishi M; Ogawa K; Natsuizaka M; Yamamoto Y; Asaka M
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1431-6. PubMed ID: 18854000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of quantitative hepatitis B virus DNA levels in serum and liver biopsy samples of chronic hepatitis B patients].
    Rüzgar M; Cetin Akhan S; Vahaboğlu H
    Mikrobiyol Bul; 2008 Apr; 42(2):283-91. PubMed ID: 18697426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Bax/Bcl-2 ratio up-regulates caspase-3 and increases apoptosis in the thymus of patients with myasthenia gravis.
    Salakou S; Kardamakis D; Tsamandas AC; Zolota V; Apostolakis E; Tzelepi V; Papathanasopoulos P; Bonikos DS; Papapetropoulos T; Petsas T; Dougenis D
    In Vivo; 2007; 21(1):123-32. PubMed ID: 17354625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
    Wu CH; Xu XY; Tian GS; Yu YY
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl-2 antigen expression in patients with chronic hepatitis C and advanced fibrosis.
    Gabriel A; Ziółkowski A; Dziambor AP; Radłowski P; Kropczyński G
    Med Sci Monit; 2001 May; 7 Suppl 1():181-4. PubMed ID: 12211716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 13-year longitudinal study of the impact of double mutations in the core promoter region of hepatitis B virus on HBeAg seroconversion and disease progression in patients with genotype C chronic active hepatitis.
    Jang JW; Lee YC; Kim MS; Lee SY; Bae SH; Choi JY; Yoon SK
    J Viral Hepat; 2007 Mar; 14(3):169-75. PubMed ID: 17305882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.